www.bostonherald.com
5 months agoMedicine
Ozempic mania's billions in bills are coming for US taxpayers
State and local governments in the US are facing skyrocketing costs for drugs to treat diabetes and obesity, which threatens to strain their healthcare budgets.
The high costs of drugs like Ozempic and Wegovy, priced at over $1,000 a month, are putting a burden on government healthcare programs like Medicaid and state health plans. [ more ]